Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03034928 · ClinicalTrials.gov registry record · NA
Clinical Biocompatibility Evaluation of Contact Lens Coatings
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT03034928 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 33 participants.
The verdict
NCT03034928, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The primary objective is to evaluate corneal staining observed after 2 hours of wear with contact lenses with investigational coating against PureVision™ lenses, all pre-cycled with OPTI-FREE® RepleniSH® multi-purpose disinfection solution.
Interventions
- DEVICE Contact lens with investigational coating 1
- DEVICE Balafilcon A contact lens
- DEVICE OPTI-FREE® RepleniSH® MPDS
- DEVICE Contact lens with investigational coating 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2017-02-14 |
| Est. Completion | 2017-03-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03034928
The ClinicalTrials.gov registry entry for NCT03034928 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Contact lens with investigational coating 1 is the first listed.
NCT03034928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03034928 about?
NCT03034928 is a clinical study titled "Clinical Biocompatibility Evaluation of Contact Lens Coatings". The primary objective is to evaluate corneal staining observed after 2 hours of wear with contact lenses with investigational coating against PureVision™ lenses, all pre-cycled with OPTI-FREE® RepleniSH® multi-purpose disinfection solution.
What is the current status of trial NCT03034928?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2017-02-14. Estimated completion is 2017-03-14.
What interventions are being tested in trial NCT03034928?
The interventions under investigation include: Contact lens with investigational coating 1 (DEVICE), Balafilcon A contact lens (DEVICE), OPTI-FREE® RepleniSH® MPDS (DEVICE), Contact lens with investigational coating 2 (DEVICE).
Who is sponsoring clinical trial NCT03034928?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.